Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Cáncer
6
Agentes antineoplásicos
2
Aspectos moleculares
2
Diagnóstico
2
Histopatología
2
Carcinogénesis química
1
Citodiagnóstico
1
Enfermedades
1
Enfermedades de la próstata
1
Enfermería
1
Farmacología
1
Inmunodiagnóstico
1
Mamas
1
Merkel celulas
1
Merkel celulas carcinoma
1
Oncología
1
Patofisiología
1
Próstata
1
Quimioterapia
1
-
1421por Gopal, Sandeep, Veracini, Laurence, Grall, Dominique, Butori, Catherine, Schaub, Sébastien, Audebert, Stéphane, Camoin, Luc, Baudelet, Emilie, Radwanska, Agata, Beghelli-de la Forest Divonne, Stéphanie, Violette, Shelia M., Weinreb, Paul H., Rekima, Samah, Ilie, Marius, Sudaka, Anne, Hofman, Paul, Van Obberghen-Schilling, Ellen“…Functional interplay between tumour cells and their neoplastic extracellular matrix plays a decisive role in malignant progression of carcinomas. Here we provide a comprehensive data set of the human HNSCC-associated fibroblast matrisome. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1422
-
1423
-
1424
-
1425
-
1426
-
1427
-
1428
-
1429
-
1430
-
1431
-
1432por Yun, Hyun Sil, Lee, Sun Kyung, Yoon, Gun, Kim, Hwi Gon, Lee, Dong Hyung, Na, Yong Jin, Choi, Ook Hwan, Shin, Dong Hoon, Song, Yong Jung“…Lymphoepithelioma-like carcinoma (LELC) of the uterine cervix is exceedingly uncommon. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1433
-
1434
-
1435por Morais, Christudas“…Of the many targeted therapies introduced since 2006, sunitinib has carved its way to become the most commonly used first-line therapy for the treatment of metastatic renal cell carcinoma (RCC). Despite significant improvements in progression-free survival, 30% of the patients are intrinsically resistant to sunitinib and the remaining 70% who respond initially will eventually become resistant in 6–15 months. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1436por Meskawi, Malek, Valdivieso, Roger, Dell’Oglio, Paolo, Trudeau, Vincent, Larcher, Alessandro, Karakiewicz, Pierre I.“…A phase III pivotal trial on everolimus, published in 2008, provided the first evidence for the efficacy of sequential therapy for patients with metastatic clear cell renal cell carcinoma (RCC). In this study, everolimus was used after failure of one or several previous lines of therapy, and it demonstrated a 3-month survival benefit relative to placebo. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1437“…Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1438
-
1439“…We removed the tumor tissue through lumpectomy and found that the mass was invasive ductal carcinoma. This case report highlights invasive ductal carcinoma, presenting with unilateral nipple discharge.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1440“…A diagnostic tool can be created that reliably distinguishes lobular from ductal carcinoma and allows the classification of cell lines on the basis of molecular profiles associated with these tumor types. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto